|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||13.95 - 14.41|
|52-week range||11.91 - 20.19|
|Beta (5Y monthly)||0.69|
|PE ratio (TTM)||48.03|
|Forward dividend & yield||0.11 (0.79%)|
|Ex-dividend date||30 Mar 2023|
|1y target est||N/A|
Olympus announced today that Olympus Canada Inc. has been named one of Greater Toronto's Top Employers for the eighth consecutive year.
As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today that the American Medical Association (AMA) will issue two new Category I Current Procedural Terminology (CPT®) codes for the iTind™ procedure, a minimally invasive treatment for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).